Mechanisms for the evolution of novel DNA specificity in a transcription factor f
转录因子 f 中新型 DNA 特异性的进化机制
基本信息
- 批准号:8795931
- 负责人:
- 金额:$ 6.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-17 至 2017-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAndrogen ReceptorAndrogensAnisotropyArchitectureAreaBindingBinding SitesBiochemicalBiophysical ProcessBiophysicsCalorimetryCardiovascular DiseasesCase StudyCell physiologyComparative StudyComputational TechniqueCrystallographyDNADNA BindingDNA SequenceDataDeuteriumDevelopmentDiseaseEngineeringEstrogen ReceptorsEvolutionFamilyFutureGene ExpressionGene Expression RegulationGenesGeneticGenetic EpistasisGenetic ProcessesGenetic VariationGlucocorticoidsGoalsHealthHomeostasisHormone Receptor DNA-Binding DomainHydrogenImmune System DiseasesImmunityKnowledgeLibrariesLinkMalignant NeoplasmsMapsMetabolicMethodsMineralocorticoidsModelingMutationOrganismPhenotypePhylogenetic AnalysisPhysiologyPlayProcessProtein BiochemistryProtein FamilyProteinsRecording of previous eventsRegulator GenesRelative (related person)ReporterReproductionRoleSpecificitySteroid ReceptorsStructureSystemTechniquesThermodynamicsTimeTranscriptional RegulationVariantWorkbasebiophysical techniquesdeep sequencingdriving forceexperimental analysisgenetic analysisgenetic manipulationhigh throughput screeningmolecular dynamicsnovelprotein functionreceptorreceptor bindingreconstructionreproductiveresearch studysteroid hormone receptorsuccesssynthetic biologytranscription factor
项目摘要
DESCRIPTION (provided by applicant):
We propose the first experimental analysis of the mechanisms by which transcription factors (TFs) evolved specificity for new DNA binding sites. The diversity and specificity of TFs allows organisms to precisely regulate cellular processes in development and physiology; modulation of TF action is also a critical means by which organisms evolve. But little is known about the mechanisms and dynamics by which TF's evolved their DNA specificities. Comparative studies of extant proteins have had limited success, because the causes of protein diversity occurred in the deep past, so historical approaches are required to distinguish them from the many other changes that have accrued since that time. Here we combine a powerful strategy for analyzing evolutionary mechanisms and processes-ancestral protein reconstruction-with advanced biophysical analysis and high-throughput screening of variant protein libraries to analyze the evolution of DNA specificity in the steroid hormone receptor (SR) protein family, a superb model of TF diversification. SRs play key roles in development, reproduction, homeostasis, cancer, and many diseases. The two classes of SRs-estrogen receptors on one hand and the receptors for androgens, progestagens, glucocorticoids, and mineralocorticoids (APGMRs) on the other-recognize different DNA binding sites. Preliminary data indicate that this diversity evolved via a sharp shift in DNA recognition that occurred between the ancestor of all steroid receptors (AncSR1) and the ancestor of the APGMRs (AncSR2). Our goals are to: 1) Dissect this evolutionary shift by combining phylogenetic inference with functional and biochemical/ biophysical techniques to "resurrect" AncSR1 and AncSR2 and experimentally characterize them; 2) Identify the historical mutations that switched DNA specificity and characterize the mechanisms by which they did so, using targeted genetic manipulations and experimental analysis in ancestral backgrounds; 3) Identify permissive mutations that were required for AncSR1 to tolerate the mutations that shifted its DNA recognition and determine the mechanisms for their effects; and 4) Develop a new high-throughput method to identify the functional effects and interactions of all historical mutations between AncSR1 and AncSR2. Our experiments will establish a complete mechanistic account for the evolution of novel TF specificity, linking historical genetic changes to shifts in protein function and biochemistry that
generated a new gene regulatory system. This complete causal chain will elucidate how the biophysical architecture of extant proteins evolved and how that architecture structured the evolutionary genetic process. As the first-of-its-kind case study of the mechanistic evolution of TF function, this project will establish a methodological exemplar for future studies. Because the architecture of SR binding to DNA is classical, our work will establish baseline knowledge of evolutionary processes that is likely to apply to other TF families. The resulting structure-function knowledge will facilitate efforts to engineer TFs with new DNA-binding specificities in synthetic biology and biomedicine.
描述(由申请人提供):
我们提出了第一个实验分析的机制,转录因子(TF)进化特异性新的DNA结合位点。TF的多样性和特异性使生物体能够精确地调节发育和生理学中的细胞过程; TF作用的调节也是生物体进化的关键手段。但是对于TF进化出它们的DNA特异性的机制和动力学知之甚少。对现存蛋白质的比较研究取得了有限的成功,因为蛋白质多样性的原因发生在遥远的过去,因此需要历史方法将它们与自那时以来发生的许多其他变化区分开来。在这里,我们联合收割机一个强大的战略,用于分析进化机制和过程的祖先蛋白质重建先进的生物物理分析和高通量筛选的变体蛋白质库,以分析DNA特异性的类固醇激素受体(SR)蛋白质家族,TF多样化的一个极好的模型的演变。SR在发育、生殖、稳态、癌症和许多疾病中起关键作用。这两类SR--一方面是雌激素受体,另一方面是雄激素、孕激素、糖皮质激素和盐皮质激素受体(APGMR)--识别不同的DNA结合位点。初步数据表明,这种多样性是通过所有类固醇受体的祖先(AncSR 1)和APGMR的祖先(AncSR 2)之间发生的DNA识别的急剧变化而进化的。我们的目标是:1)通过将系统发育推断与功能和生物化学/生物物理技术相结合来“复活”AncSR 1和AncSR 2并实验表征它们,来剖析这种进化转变; 2)使用针对性遗传操作和祖先背景中的实验分析,鉴定切换DNA特异性的历史突变并表征它们这样做的机制; 3)鉴定AncSR 1耐受改变其DNA识别的突变所需的允许突变,并确定其作用的机制;和4)开发新的高通量方法来鉴定AncSR 1和AncSR 2之间所有历史突变的功能效应和相互作用。我们的实验将为新型TF特异性的进化建立一个完整的机制,将历史遗传变化与蛋白质功能和生物化学的变化联系起来,
产生了一个新的基因调控系统。这个完整的因果链将阐明现存蛋白质的生物物理结构是如何进化的,以及这种结构是如何构建进化遗传过程的。作为TF功能机制演化的第一个案例研究,该项目将为未来的研究建立一个方法学范例。由于SR与DNA结合的结构是经典的,我们的工作将建立可能适用于其他TF家族的进化过程的基线知识。由此产生的结构-功能知识将有助于在合成生物学和生物医学中设计具有新DNA结合特异性的TF。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jamie T Bridgham其他文献
Jamie T Bridgham的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jamie T Bridgham', 18)}}的其他基金
Mechanisms for the evolution of novel DNA specificity in a transcription factor f
转录因子 f 中新型 DNA 特异性的进化机制
- 批准号:
8579746 - 财政年份:2013
- 资助金额:
$ 6.46万 - 项目类别:
Mechanisms for the evolution of novel DNA specificity in a transcription factor f
转录因子 f 中新型 DNA 特异性的进化机制
- 批准号:
8734454 - 财政年份:2013
- 资助金额:
$ 6.46万 - 项目类别:
Mechanisms for the evolution of novel DNA specificity in a transcription factor f
转录因子 f 中新型 DNA 特异性的进化机制
- 批准号:
8850880 - 财政年份:2013
- 资助金额:
$ 6.46万 - 项目类别:
相似海外基金
Androgen receptor: A master regulator of lipid metabolism
雄激素受体:脂质代谢的主要调节因子
- 批准号:
DP230103210 - 财政年份:2023
- 资助金额:
$ 6.46万 - 项目类别:
Discovery Projects
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
通过蛋白质精氨酸甲基化调节前列腺癌中的雄激素受体信号传导
- 批准号:
10584689 - 财政年份:2023
- 资助金额:
$ 6.46万 - 项目类别:
Structural and functional analysis of a novel class of androgen receptor antagonists
一类新型雄激素受体拮抗剂的结构和功能分析
- 批准号:
10650956 - 财政年份:2023
- 资助金额:
$ 6.46万 - 项目类别:
Role of the Androgen Receptor in Insulin Secretion in the Male
雄激素受体在男性胰岛素分泌中的作用
- 批准号:
10488954 - 财政年份:2023
- 资助金额:
$ 6.46万 - 项目类别:
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
靶向肿瘤细胞巨噬细胞脂质相互作用以克服对雄激素受体靶向治疗的耐药性
- 批准号:
10651105 - 财政年份:2023
- 资助金额:
$ 6.46万 - 项目类别:
Preclinical development of ONCT-505, an Androgen Receptor Antagonist and Degrader, as new potential therapeutic for Kennedy's Disease
ONCT-505(一种雄激素受体拮抗剂和降解剂)的临床前开发,作为肯尼迪病的新潜在治疗方法
- 批准号:
10603636 - 财政年份:2023
- 资助金额:
$ 6.46万 - 项目类别:
Proliferating cell nuclear antigen in regulation of androgen receptor signalings in castration-resistant prostate cancer cells
增殖细胞核抗原对去势抵抗性前列腺癌细胞雄激素受体信号传导的调节
- 批准号:
10544062 - 财政年份:2022
- 资助金额:
$ 6.46万 - 项目类别:
Effects of androgen receptor (AR) signaling on CD4+ T cell metabolism during airway inflammation
气道炎症期间雄激素受体 (AR) 信号对 CD4 T 细胞代谢的影响
- 批准号:
10534943 - 财政年份:2022
- 资助金额:
$ 6.46万 - 项目类别:
TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
标题:使用雄激素受体抑制剂阿帕鲁胺进行膀胱癌化学预防
- 批准号:
10677989 - 财政年份:2022
- 资助金额:
$ 6.46万 - 项目类别: